Cardiovascular Disease Prevention Continuing Medical Education, CME, Medical Conference - Baptist Health
Skip Ribbon Commands Skip to main content
 
2015
Cardiovascular Disease Prevention
13th Annual International Symposium
Thursday - Sunday, February 19-22, 2015
Fontainebleau Hotel, Miami Beach, Florida
Register

2015 Faculty________________________________

Symposium Directors



Michael Ozner, M.D., FACC, FAHA

Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Voluntary Assistant Professor of Medicine (Cardiology)
University of Miami Miller School of Medicine
Miami, Florida

Biography:   Dr. Ozner is one of America’s leading advocates for heart disease prevention. He is a well-known regional and national speaker in the field of preventive cardiology. Dr. Ozner has frequently appeared in the print, radio and television media including The New York Times, NPR radio and CBS News. He was the recipient of the 2008 American Heart Association Humanitarian Award and has been elected to Top Cardiologists in America by the Consumer Council of America. Dr. Ozner is also the author of The Great American Heart Hoax and Heart Attack Proof. His most recent book, The Complete Mediterranean Diet, was released worldwide April 2014.


Theodore Feldman, M.D., FACC, FACP

Medical Director, Miami Cardiac & Vascular Institute at South Miami Hospital
Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Clinical Associate Professor of Medicine
Florida International University Herbert Wertheim College of Medicine
Miami, Florida


Arthur S. Agatston, M.D., FACC

Medical Director, Center for Prevention and Wellness
Baptist Health South Florida
Cardiologist, Baptist Hospital of Miami
Associate Professor of Medicine, University of Miami Miller School of Medicine
Miami, Florida

Biography:    Dr. Agatston’s work with Dr. Warren Janowitz resulted in the Agatston Score, a method of screening for coronary calcium as an indicator of atherosclerosis that is used at medical centers throughout the world and considered by most experts to be the best single predictor of a future heart attack. His cardiology practice in Miami Beach is focused on preventing heart attacks in high-risk patients. Known as the author of the internationally best-selling book, The South Beach Diet, his first nonacademic work, Dr. Agatston created his balanced approach to healthy eating to help his patients improve their blood chemistries and lose weight. Dr. Agatston has published more than 100 scientific articles and abstracts in medical journals and is a frequent lecturer across the U.S. and around the world on diet, cardiac imaging, and the prevention of heart disease. In recognition of his contributions to cardiac prevention, the Society of Cardiovascular Computed Tomography (SCCT) created the prestigious Arthur S. Agatston Cardiovascular Disease Prevention Award in 2011, which is given annually to pioneers in cardiac prevention.


Khurram Nasir, M.D., MPH

Research Director, Center for Prevention and Wellness
Director, High-risk Cardiovascular Disease Clinic
Baptist Health South Florida, Miami, Florida
Assistant Professor, Johns Hopkins Ciccarone Center for Preventive Cardiology
Baltimore, Maryland

Biography:    Dr. Nasir’s area of expertise lies in population health management, role of cardiovascular imaging for identification of high-risk individuals with a particular emphasis on innovative health care delivery based paradigms to improve patient outcomes and appropriate resource allocation. Dr. Nasir is a recipient of the NIH training award for cardiac imaging training program at the Massachusetts General Hospital, Boston, USA.  Dr. Nasir has published more than 290 publications in his area of interest. He is an Associate Editor for the journal, “Atherosclerosis”, “Circulation: Cardiovascular Quality and Outcomes” and “Journal of American Cardiology: Cardiac Imaging” as well serves on the editorial board for the Journal of Cardiac CT.  He is currently the chair of prevention council for the Society of Atherosclerosis Imaging and Prevention as well member of board of directors for Society for Cardiac CT (SCCT). He was awarded in 2013 for his contributions the “Johns Hopkins Distinguished Alumni Award”, which honors alumni who have typified the Johns Hopkins tradition of excellence and brought credit to the University by their personal accomplishment, professional achievement, or humanitarian service.


Guest Faculty


Christie Ballantyne, M.D.

Donald P. Chapman Endowed Chair of Cardiology, Section of Cardiology, Department of Medicine
Chief, Section of Cardiovascular Research, Department of Medicine
Director, Center for Cardiovascular Disease Prevention, The Methodist DeBakey Heart and Vascular Center and Baylor College of Medicine
Chief, Section of Atherosclerosis and Peripheral Arterial Disease, Department of Cardiology, The Methodist DeBakey Heart and Vascular Center
Professor, Departments of Medicine and Genetics, Baylor College of Medicine
Houston, Texas

Biography:    Dr. Ballantyne is editorial director for www.lipidsonline.org. He has published extensively and has spoken nationally and internationally on lipids, atherosclerosis and inflammation. Dr. Ballantyne's research interests include the pathophysiology of atherosclerosis, with an emphasis on monocyte activation and adhesion. His clinical interests include preventive cardiology, lipids, metabolic syndrome, atherosclerosis, genetics, and coronary artery disease.




Harold E. Bays MD, FTOS, FACC, FACE, FNLA
Medical Director / President
Louisville Metabolic and Atherosclerosis Research Center, Inc. (L-MARC Research Center)
Louisville, Kentucky

Biography:    Dr. Bays has served as a principal investigator for over 400 clinical trials including investigational pharmacotherapies for dyslipidemia, obesity, diabetes mellitus, hypertension, osteoporosis, osteoarthritis and other metabolic disorders. He has written or served as a contributing author to over 200 scientific manuscripts and book chapters, and authored/presented over 100 scientific abstracts.
 
  
Kevin L Billups, M.D.
Associate Professor of Urology and Medicine (Preventive Cardiology)
Johns Hopkins Medicine
Director, Integrative Men’s Health Program
Brady Urological Institute
Baltimore, Maryland

Biography:    Dr. Billups’ area of clinical and research expertise involves the use of erectile dysfunction and testosterone deficiency as gender-specific markers for early detection and prevention of chronic medical conditions, such as diabetes, heart disease and hypertension. He also has expertise in penile prosthetic surgery for men who do not respond to medical management. Dr. Billups is actively involved in creating a multidisciplinary men’s health program that addresses both traditional medical therapies and the social determinants of health to promote prevention and early stage management of the chronic medical diseases which are known to be major contributors to premature death and suffering among men.


Michael Joseph Blaha, M.D., MPH
Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease
Assistant Professor of Medicine
Johns Hopkins Hospital
Baltimore, Maryland

Biography:    Dr. Blaha’s research interest is in the prevention of heart attacks. His primary work with the Ciccarone Center includes improving cardiovascular risk prediction through novel methods of early detection of atherosclerosis including the use of cardiac computed tomography. Dr. Blaha has worked for the last 7 years on the Multi- Ethnic Study of Atherosclerosis (MESA), an NIH-funded study that seeks to explain the distribution and progression of early atherosclerosis amongst healthy people. He received a Young Investigator Award from MESA in 2011 for his work that was published in the Lancet Medical Journal.


Roger Blumenthal, M.D.   
Kenneth Jay Pollin Professor of Cardiology
Director, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
Baltimore, Maryland

Biography:    An expert in noninvasive detection of vascular disease, Dr. Blumenthal was also on the AHA’s official writing group about the utility of cardiac CT and CT angiography. He also was a member of the ACC task force dealing with selection of patients for atherosclerosis imaging techniques such as ultrafast CT scanning and carotid ultrasound. He is now vice president of the American Society of Preventive Cardiology. In 2010 he was presented with the David Levine Award for Excellence in Mentoring of postdoctoral fellows, residents and junior faculty in the Johns Hopkins Department of Medicine.


Michael H. Davidson, M.D., FACC, FACP, FNLA
Clinical Professor, Director of Preventive Cardiology
The University of Chicago Pritzker School of Medicine
Chicago, Illinois

Biography:    An active researcher, Dr. Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area. A prolific author and lecturer on lipid disorders, nutrition and atherosclerosis, Dr. Davidson has coordinated more than 1,000 clinical trials in areas of preventive cardiology. He has published more than 250 articles for leading medical journals and has written three books on lipidology.


Thomas Dayspring, M.D., FACP, FNLA, NCMP
Director of Cardiovascular Education
Foundation for Health Improvement and Technology
Wayne, New Jersey

Biography:    Dr. Dayspring is the author of several textbook chapters and peer-reviewed articles, CME publications relating to lipids (including strerols) and lipoproteins including their pharmacologic modulation and their relationship to gender, estrogen and raloxifene. He also authors “Lipidaholics Anonymous” a newsletter received by several thousand healthcare professionals.


Ian del Conde Pozzi, M.D.
Cardiovascular Disease, Vascular Medicine
Baptist, Doctors, Homestead and West Kendall Baptist Hospitals
Miami, Florida

Biography:    Dr. del Conde Pozzi’s clinical expertise involves the study and treatment of diseases that affect the arterial, venous, and lymphatic systems, including peripheral artery disease, carotid and renal artery disease, resistant hypertension, venous thromboembolic disease, venous insufficiency and less common vascular diseases, such as fibromuscular dysplasia, and vasculitis. Dr. del Conde Pozzi has focused his career on the study of thrombosis and vascular diseases. He has published widely in the field of cardiovascular diseases and is the author of several scientific articles and book chapters and has been an invited speaker at several international medical meetings.



Carl E. Fulwiler, M.D., Ph.D.
Associate Professor of Psychiatry
Director, Systems and Psychosocial Advances Research Center
University of Massachusetts Medical School
Boston, Massachusetts

Biography:    Combining health services research with neuroimaging, Dr. Fulwiler’s work has focused on developing and evaluating services for individuals with co-occurring mental health and substance abuse disorders, and on mindfulness-based interventions for wellness. He has received professional training in Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy for Depression (MBCT). Dr. Fulwiler is currently conducting an NIH-funded study using neuroimaging to understand the impact of MBSR on neural mechanisms of emotion regulation and health behaviors involved in successful weight loss. 



Anne C. Goldberg, M.D. 
Associate Professor of Medicine
Division of Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
St. Louis, Missouri

Biography:    Dr. Goldberg has participated in numerous clinical trials involving the use of lipid-modifying agents, including the Lipid Research Clinics Coronary Primary Prevention Trial which was one of the first to show that lowering blood cholesterol levels decreases risk of coronary artery disease. Other work has focused on studies of the effects on lipids and lipoproteins of diet, soluble fiber, and a variety of drugs with different mechanisms of action. Drug classes studied include bile acid sequestrant resins, nicotinic acid, HMG CoA reductase inhibitors, cholesterol absorption inhibitors, and fibric acid derivatives as well as novel lipid-lowering agents. Her clinical research has included Phase 2 through Phase 4 studies as well as outcome studies.


Timothy Grant, M.D.
Medical Director, Baptist Sleep Center
Baptist, South Miami, Homestead and Mariners Hospitals
Miami, Florida

Biography:    Dr. Grant earned his medical degree at the University of Miami Miller School of Medicine, and completed an internship and residency at Jackson Memorial Hospital and Veterans Administration Hospital. He is certified by the American Boards of Sleep medicine, and Psychiatry and Neurology, as well as the National Board of Medical Examiners. With over 30 years of experience in neurology, Dr. Grant is recognized as an expert in sleep medicine. He specializes in the study and treatment of sleep disorders, and is a frequent lecturer in the field of sleep medicine.


Peter Katzmarzyk, Ph.D., FACSM, FAHA
Professor and Associate Executive Director
Population and Public Health Sciences Pennington Biomedical Research Center
Marie Edana Corcoran Endowed Chair in Pediatric Obesity and Diabetes
Baton Rouge, Louisiana

Biography:    Dr. Karzmarzyk’s main research interest is the epidemiology and public health impact of obesity and physical inactivity and determining the relationships between physical activity, physical fitness, obesity and related disorders such as metabolic syndrome, cardiovascular disease and diabetes, particularly in children and youth. Dr. Katzmarzyk has published his research findings in more than 300 scholarly journals and books, and regularly participates in the scientific meetings of several national and international organizations. He is currently an editorial board member for the International Journal of Obesity, International Journal of Pediatric Obesity, Journal of Physical Activity and Health, and Metabolic Syndrome and Related Disorders. Dr. Katzmarzyk was recently appointed to serve on the President’s Council on Fitness, Sports & Nutrition Science Board.


Italo Linfante, M.D., FAHA
Medical Director, Interventional Neuroradiology and Endovascular Neurosurgery
Baptist Health Neuroscience Center and Miami Cardiac & Vascular Institute
Interventional Neuroradiologist
Baptist and South Miami Hospitals
Clinical Associate Professor, Department of Radiology, Neurology and Neurosurgery
FIU Herbert Wertheim College of Medicine
Miami, Florida

Biography:    Dr. Linfante has participated in several clinical trials of drugs and a technology related to stroke and other cerebrovascular conditions and has lectured nationally and internationally on related topics. Dr. Linfante has been a member of the editorial board of the scientific journal Stroke since 2002 and on the editorial board of the Journal of Neuro Interventional Surgery. He has been a guest editor for several other peer-reviewed medical journals. He is the author of more than 70 scientific articles published in world renowned peer-reviewed journals such as Stroke, Neurology and Neurosurgery. He has published numerous book chapters and books on stroke and cerbrovascular diseases.


Vasanti Malik, Sc.D.
Research Associate, Department of Nutrition
Harvard School of Public Health
Boston, Massachusetts

Biography:    Dr. Malik’s research focuses on evaluating dietary risk factors for obesity, type 2 diabetes and cardiovascular disease. Much of her work has evaluated the health effects of sugar-sweetened beverages. She has published extensively on this topic, including a number of influential review papers and meta-analyses. More recent research interests of Dr. Malik include studying nutritional drivers of the global obesity and diabetes epidemics in countries undergoing epidemiologic transition. The ultimate goal of her work is to inform future large-scale community-based interventions and policy strategies to reduce the risk of obesity and related chronic diseases nationally and internationally.


Peter A. McCullough, MD, MPH, FACC, FACP, FCCP, FAHA, FNKF
Vice Chief of Medicine
Baylor University Medical Center
Dallas, Texas

Biography:  
  Dr. McCullough is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state. He has over 1000 publications including the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is the current Chair of the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP), the nation’s largest community screening effort for chronic diseases. He is the co-editor of Reviews in Cardiovascular Medicine and serves on the editorial boards of multiple specialty journals.


Suzanne Oparil, M.D.
Distinguished Professor of Medicine
Professor of Cell, Developmental and Integrative Biology
Director, Vascular Biology and Hypertension Program
Division of Cardiovascular Disease, Department of Medicine
University of Alabama
Birmingham, Alabama

Biography:    Dr. Oparil currently serves as co-chair of JNC 8, the Joint National Committee charged by NHLBI with developing U.S. guidelines for the prevention, detection, evaluation and treatment of high blood pressure. Dr. Oparil has made many seminal contributions to vascular biology and hypertension research. She has served as principal investigator of over 30 clinical research projects and has been continuously funded by the NIH for 30 years. She serves on various editorial boards and has an extensive publication record, consisting of over 700 journal articles and books or book chapters on topics in clinical cardiology, atherosclerosis, heart failure, vascular biology and hypertension. Dr. Oparil has received a number of honorary memberships, lectureships, lifetime achievement awards and distinguished awards for her significant contributions to the field of hypertension research.


Carl E. Orringer, M.D.
Director, Preventive Cardiovascular Medicine Program
University of Miami Miller School of Medicine
Miami, Florida

Biography:
Dr. Orringer is a co-author of the NLA recommendations. He is a fellow of the ACC and the NLA, where he is president-elect. 


Wendy Susan Post, M.D., MS
Professor of Medicine, Johns Hopkins University School of Medicine
Professor of Epidemiology,  Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland

Biography:    Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, and cardiovascular disease in HIV/AIDS. She is the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA) and for the Multi-Center AIDS Cohort Study (MACS) Cardiovascular Disease sub-study. Dr. Post is currently associate editor of American Journal of Epidemiology and a consulting and guest editor for Circulation. She is a manuscript reviewer for multiple publications, and has over 130 peer-reviewed research publications.


Goutham Rao, M.D.
Vice Chair, Department of Family Medicine
North Shore University Health System and University of Chicago
Director, Ambulatory Primary Care Innovations Group
Director, Center for Biomedical Research Informatics
North Shore University Health System
Clinical Associate Professor, University of Chicago Pritzker School of Medicine
Evanston, Illinois

Biography:   Dr. Rao is the author of more than 50 publications, including three books. He is Editor-in-Chief of Medical Education Development. Dr. Rao’s research interests include the use of technology to improve delivery of preventive services. As his clinical and research work has most recently been in the field of childhood obesity, Dr. Rao is pursuing funding to develop systematic approaches to identifying cardiovascular risks in children, and funding to develop financial-incentive based strategies to help adolescents achieve a healthy weight.



Rita Redberg, M.D., M.Sc., FACC
Professor and Director, Women's Cardiovascular Services
University of California San Francisco
San Francisco, California
 
Biography:    Dr. Redberg is currently chief editor of JAMA Internal Medicine and has spearheaded the journal’s new focus on health care reform and “less is more,” highlighting areas of health-care with no known benefit and definite risks. Dr. Redberg’s research interests are in the area of health policy and technology assessment. Her work includes comparative effectiveness research and focuses on how evidence relates to FDA approval, insurance coverage and medical guidelines and practice. Dr. Redberg has written, edited and contributed to many books, including You Can Be a Woman Cardiologist, Heart Healthy: The Step-by-Step Guide to Preventing and Healing Heart Disease and Coronary Disease in Women: Evidence-based Diagnosis and Treatment.


Paul Ridker, M.D., MPH, FACC, FAHA
Director, Center for Cardiovascular Disease Prevention
Division of Preventive Medicine
Brigham and Women’s Hospital
Eugene Braunwald Professor of Medicine
Harvard Medical School
Boston, Massachusetts
 
Biography:
    Dr. Ridker’s research focuses on the design and conduct of multinational randomized trials, the development of inflammatory biomarkers for clinical and research use, the molecular and genetic epidemiology of cardiovascular diseases and novel strategies for cardiovascular disease detection and prevention. As a preventive cardiologist, Dr. Ridker is best known for his work developing the inflammatory hypothesis of heart disease, the clinical application of high sensitivity C-reactive protein (hsCRP) testing as a method to better evaluate cardiovascular risk, and the demonstration in 2008 in the large-scale JUPITER trial that statin therapy is highly effective at reducing heart attack and stroke when given to men and women with elevated hsCRP levels. Currently, Dr. Ridker serves as trial chairman and principal investigator of two multinational, randomized, placebo-controlled clinical trials designed to address whether reducing inflammation can reduce cardiovascular event rates. These trials are the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) and the NHLBI funded Cardiovascular Inflammation Reduction Trial (CIRT).
   

Prediman K. Shah, M.D., FACC, FACP, FCCP
Professor of Medicine
David Geffen School of Medicine
University of California, Los Angeles
Director, Division of Cardiology
Director, Atherosclerosis Research Center
Shapell and Webb Family Endowed Chair in Cardiology
Cedars-Sinai Heart Institute
Los Angeles, California
 
Biography: 
   In 1992, Dr. Shah and his colleagues began studying a mutant gene that was found in a small number of inhabitants of a northern Italian town. Compared to the normal gene (apolipoprotein A-1), the mutant gene (apo A-1 Milano) produces a form of HDL (high-density lipoprotein or "good" cholesterol) that provides greater protection against atherosclerosis and vascular inflammation processes that lead to clogged arteries, heart attacks, and strokes. Animal studies conducted in Dr. Shah's laboratory and the laboratory of his longtime collaborator, Swedish scientist Dr. Jan Nilsson, found that a vaccine created from the low-density lipoprotein (LDL, or "bad" cholesterol) molecule significantly reduced plaque buildup in animals that had high cholesterol levels. Experimental studies on this novel vaccine for heart disease continue and human studies are planned within the next few years.


Allan D. Sniderman, M.D., FRCP(C), FRSC
Edwards Professor of Cardiology
Professor of Medicine
McGill University
Director, Mike Rosenbloom Laboratories for Cardiovascular Research
Montreal, Quebec, Canada

Biography:    With colleagues within and outside McGill, Dr. Sniderman began and has continued a series of studies that identified the commonest dyslipoproteinemia associated with coronary artery disease – hyperTg hyperapoB. These studies also demonstrated apoB to be superior to LDL-cholesterol as a marker of the risk of vascular disease. His current research interests are: to understand the regulation of plasma LDL, to create simplified but advanced diagnostic algorithms to recognize and treat those with and those at high risk of vascular disease, and to develop new models to determine the absolute value of different strategies to identify and treat those at risk of vascular disease.






  


  

Disclosures and Resolution of Conflict of Interest
Baptist Health South Florida requires resolution of all conflicts of interest to ensure balance, independence, objectivity, and scientific rigor in all CME programming. Conflicts of interest of any individuals who control CME content will be identified and resolved prior to this educational activity. Full disclosure will be made in the syllabus. Presenters will also disclose discussion of off-label uses.